These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 525991)

  • 1. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.
    Carrizosa J; Santoro J; Kaye D
    Antimicrob Agents Chemother; 1978 Jan; 13(1):74-7. PubMed ID: 626493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J; Carrizosa J; Kaye D; Kobasa WD
    J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF; Sande MA
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bactericidal titer as a predictor of outcome in endocarditis.
    Hackbarth CJ; Chambers HF; Sande MA
    Eur J Clin Microbiol; 1986 Feb; 5(1):93-7. PubMed ID: 2938947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M; Rouse M; Henry N; Wilson W
    Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Archer GL; Vazquez GJ; Johnston JL
    J Infect Dis; 1980 Nov; 142(5):725-31. PubMed ID: 7462687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.
    Miller MH; Wexler MA; Steigbigel NH
    Antimicrob Agents Chemother; 1978 Sep; 14(3):336-43. PubMed ID: 251069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nafcillin therapy for Staphylococcus aureus endocarditis.
    Masur H; Murray HW; Roberts RB
    Antimicrob Agents Chemother; 1978 Sep; 14(3):457-61. PubMed ID: 708023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
    Vazquez GJ; Archer GL
    Antimicrob Agents Chemother; 1980 Feb; 17(2):280-5. PubMed ID: 7387148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Miller MH
    J Infect Dis; 1987 Mar; 155(3):581-5. PubMed ID: 3643249
    [No Abstract]   [Full Text] [Related]  

  • 15. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
    Berry AJ; Johnston JL; Archer GL
    Antimicrob Agents Chemother; 1986 May; 29(5):748-52. PubMed ID: 3460523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model.
    Carrizosa J; Kobasa WD; Snepar R; Kaye KM; Kaye D
    J Antimicrob Chemother; 1982 May; 9(5):387-93. PubMed ID: 6980218
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits.
    McColm AA; Ryan DM; Acred P
    J Antimicrob Chemother; 1984 Oct; 14(4):373-7. PubMed ID: 6389474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefoperazone treatment of experimental endocarditis.
    Snepar RA; Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1981 May; 19(5):773-6. PubMed ID: 6457556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.
    Fass RJ
    J Infect Dis; 1984 Jun; 149(6):904-12. PubMed ID: 6736681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antibiotic therapy in prosthetic endocarditis due to Staphylococcus epidermidis.
    Shainhouse JZ
    Can Med Assoc J; 1978 Sep; 119(6):556-8. PubMed ID: 709444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.